Evidence map›Paper›PMID 24948120›Full record

ReviewNature reviews. Drug discovery2014

Emerging targets in neuroinflammation-driven chronic pain.

Ru-Rong Ji, Zhen-Zhong Xu, Yong-Jing Gao

Registry-linked trialAbstract readReview
In one paragraph

Review in Nature reviews. Drug discovery, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04247100 (A Pilot Study of a Randomized Sham-control Auricular TENS Unit Stimulation to Improve Symptoms Through Vagal Modulation in Pediatric Functional Gastrointestinal Disorders), which is not on this map. Cited by 609 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
609citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04247100 naterminatednot on this mapstarted 2020, after this paper: background citation

A Pilot Study of a Randomized Sham-control Auricular TENS Unit Stimulation to Improve Symptoms Through Vagal Modulation in Pediatric Functional Gastrointestinal Disorders

TypeinterventionalSponsorGisela Grotewold ChelimskyRan2020 to 2021Enrolled10ConditionsFunctional Gastrointestinal Disorders, Vagus Nerve Autonomic Disorder, Irritable Bowel Syndrome, NauseaArmsTranscutaneous Electrical Nerve Stimulation (TENS), Sham Transcutaneous Electrical Nerve Stimulation
3 · Its place in the literature

Who cites it

609 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Glial cells in neuropathic pain.Physiological reviews · 2026
    Review
  5. Article
  6. Review
  7. Article
  8. NabioRxiv : the preprint server for biology · 2026
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. [Advances in innate immune-mediated neuroinflammatory mechanisms of migraine].Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences · 2026
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

549 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ru-Rong JiDepartments of Anesthesiology and Neurobiology, Duke University Medical Center, 595 LaSalle Street, Durham, North Carolina 27710, USA.
Zhen-Zhong XuDepartments of Anesthesiology and Neurobiology, Duke University Medical Center, 595 LaSalle Street, Durham, North Carolina 27710, USA.
Yong-Jing GaoPain Research Laboratory, Institute of Nautical Medicine, Jiangsu Key laboratory of Neuroregeneration, Nantong University, 19 Qixiu Road, Nantong 226001, Jiangsu 226001, China.

Funding

Neuronal and glial interactions of neuropathic painR01DE017794 · NIDCR · DUKE UNIVERSITY · PI BUCHHEIT, THOMAS · 2006 to 2021
$6.6M
Resolvins, protectins, and chronic pain resolution.R01NS067686 · NINDS · DUKE UNIVERSITY · PI JI, RU-RONG, SERHAN, CHARLES NICHOLAS · 2009 to 2013
$2.8M
Hemichannels, Astrocytic Release, and Neuropathic PainR01DE022743 · NIDCR · DUKE UNIVERSITY · PI JI, RU-RONG, NEDERGAARD, MAIKEN · 2012 to 2016
$2.0M
Resolution of chemotherapy-induced peripheral neuropathy by novel lipid mediatorR21NS082985 · NINDS · DUKE UNIVERSITY · PI XU, ZHEN-ZHONG · 2013 to 2014
$430k
NIDCR NIH HHS R01 DE017794NIDCR NIH HHS R01 DE022743NIDCR NIH HHS R01DE17794NIDCR NIH HHS R01DE22743NINDS NIH HHS R01 NS067686NINDS NIH HHS R01NS67686NINDS NIH HHS R21 NS082985NINDS NIH HHS R21NS082985
6 · The paper itself

Abstract

Current analgesics predominately modulate pain transduction and transmission in neurons and have limited success in controlling disease progression. Accumulating evidence suggests that neuroinflammation, which is characterized by infiltration of immune cells, activation of glial cells and production of inflammatory mediators in the peripheral and central nervous system, has an important role in the induction and maintenance of chronic pain. This Review focuses on emerging targets - such as chemokines, proteases and the WNT pathway - that promote spinal cord neuroinflammation and chronic pain. It also highlights the anti-inflammatory and pro-resolution lipid mediators that act on immune cells, glial cells and neurons to resolve neuroinflammation, synaptic plasticity and pain. Targeting excessive neuroinflammation could offer new therapeutic opportunities for chronic pain and related neurological and psychiatric disorders.

Indexed as

AnimalsAnti-Inflammatory AgentsChemokinesChronic PainHumansInflammationNervous System DiseasesPeptide HydrolasesWnt ProteinsAnti-Inflammatory AgentsChemokinesPeptide HydrolasesWnt Proteins

Identifiers

PMID24948120
PMCPMC4228377

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.